Tags : failure

Clinical Trials Pharma

Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR

Shots: The P-III EMPEROR Trial involves assessing of Jardiance (10 mg) vs PBO in two studies EMPEROR-Reduced [NCT03057977, N=3,730] & EMPEROR-Preserved [NCT03057951, N=5,990] in patients with HFrEF & HFpEF respectively The EMPEROR-Reduced study meets its 1EPs in reducing the risk for the composite of cardiovascular death or hospitalization due to heart failure while the overall […]Read More

Pharma

Smith Medical Recalls Medfusion 4000 Syringe Pump Due to its

Shots: Smith Medical has recalled its Medfusion 4000 syringe pump with firmware version 1.7.0 due to malfunctioning alarms and potential interruption of therapy. The FDA has labeled it as Class I recall The 627 devices have recalled having model numbers are 4000-0107-01 and 4000-0106-01, manufactured on Jun 25, 2019, and distributed b/w Sept 27, 2019, […]Read More